Report cover image

Global Dry Powder Injectables Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 108 Pages
SKU # APRC20354175

Description

Summary

According to APO Research, The global Dry Powder Injectables market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Dry Powder Injectables is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Dry Powder Injectables is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Dry Powder Injectables is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Dry Powder Injectables include Unison Chemical Works, Sakar Healthcare, Pace Biotech, Krosyl Pharma, Iskon Remedies, Flagship Biotech International Pvt Ltd, Cosmas Pharmacls, Captab Biotec and Bliss GVS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dry Powder Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Powder Injectables.

The Dry Powder Injectables market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dry Powder Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Dry Powder Injectables Segment by Company

Unison Chemical Works
Sakar Healthcare
Pace Biotech
Krosyl Pharma
Iskon Remedies
Flagship Biotech International Pvt Ltd
Cosmas Pharmacls
Captab Biotec
Bliss GVS
Aqua Vitoe Lab
ANG Lifesciences

Dry Powder Injectables Segment by Type

Small Capacity:Below 10ml
Large Capacity:Above 10ml

Dry Powder Injectables Segment by Application

Healthcare
Cosmetic
Medical
Others

Dry Powder Injectables Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Powder Injectables market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Powder Injectables and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Powder Injectables.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Powder Injectables manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Dry Powder Injectables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

108 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Dry Powder Injectables Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Dry Powder Injectables Sales Estimates and Forecasts (2020-2031)
1.3 Dry Powder Injectables Market by Type
1.3.1 Small Capacity:Below 10ml
1.3.2 Large Capacity:Above 10ml
1.4 Global Dry Powder Injectables Market Size by Type
1.4.1 Global Dry Powder Injectables Market Size Overview by Type (2020-2031)
1.4.2 Global Dry Powder Injectables Historic Market Size Review by Type (2020-2025)
1.4.3 Global Dry Powder Injectables Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Dry Powder Injectables Sales Breakdown by Type (2020-2025)
1.5.2 Europe Dry Powder Injectables Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Dry Powder Injectables Sales Breakdown by Type (2020-2025)
1.5.4 South America Dry Powder Injectables Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Dry Powder Injectables Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Dry Powder Injectables Industry Trends
2.2 Dry Powder Injectables Industry Drivers
2.3 Dry Powder Injectables Industry Opportunities and Challenges
2.4 Dry Powder Injectables Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Dry Powder Injectables Revenue (2020-2025)
3.2 Global Top Players by Dry Powder Injectables Sales (2020-2025)
3.3 Global Top Players by Dry Powder Injectables Price (2020-2025)
3.4 Global Dry Powder Injectables Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Dry Powder Injectables Major Company Production Sites & Headquarters
3.6 Global Dry Powder Injectables Company, Product Type & Application
3.7 Global Dry Powder Injectables Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Dry Powder Injectables Market CR5 and HHI
3.8.2 Global Top 5 and 10 Dry Powder Injectables Players Market Share by Revenue in 2024
3.8.3 2023 Dry Powder Injectables Tier 1, Tier 2, and Tier 3
4 Dry Powder Injectables Regional Status and Outlook
4.1 Global Dry Powder Injectables Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Dry Powder Injectables Historic Market Size by Region
4.2.1 Global Dry Powder Injectables Sales in Volume by Region (2020-2025)
4.2.2 Global Dry Powder Injectables Sales in Value by Region (2020-2025)
4.2.3 Global Dry Powder Injectables Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Dry Powder Injectables Forecasted Market Size by Region
4.3.1 Global Dry Powder Injectables Sales in Volume by Region (2026-2031)
4.3.2 Global Dry Powder Injectables Sales in Value by Region (2026-2031)
4.3.3 Global Dry Powder Injectables Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Dry Powder Injectables by Application
5.1 Dry Powder Injectables Market by Application
5.1.1 Healthcare
5.1.2 Cosmetic
5.1.3 Medical
5.1.4 Others
5.2 Global Dry Powder Injectables Market Size by Application
5.2.1 Global Dry Powder Injectables Market Size Overview by Application (2020-2031)
5.2.2 Global Dry Powder Injectables Historic Market Size Review by Application (2020-2025)
5.2.3 Global Dry Powder Injectables Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Dry Powder Injectables Sales Breakdown by Application (2020-2025)
5.3.2 Europe Dry Powder Injectables Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Dry Powder Injectables Sales Breakdown by Application (2020-2025)
5.3.4 South America Dry Powder Injectables Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Dry Powder Injectables Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Unison Chemical Works
6.1.1 Unison Chemical Works Comapny Information
6.1.2 Unison Chemical Works Business Overview
6.1.3 Unison Chemical Works Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Unison Chemical Works Dry Powder Injectables Product Portfolio
6.1.5 Unison Chemical Works Recent Developments
6.2 Sakar Healthcare
6.2.1 Sakar Healthcare Comapny Information
6.2.2 Sakar Healthcare Business Overview
6.2.3 Sakar Healthcare Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sakar Healthcare Dry Powder Injectables Product Portfolio
6.2.5 Sakar Healthcare Recent Developments
6.3 Pace Biotech
6.3.1 Pace Biotech Comapny Information
6.3.2 Pace Biotech Business Overview
6.3.3 Pace Biotech Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pace Biotech Dry Powder Injectables Product Portfolio
6.3.5 Pace Biotech Recent Developments
6.4 Krosyl Pharma
6.4.1 Krosyl Pharma Comapny Information
6.4.2 Krosyl Pharma Business Overview
6.4.3 Krosyl Pharma Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Krosyl Pharma Dry Powder Injectables Product Portfolio
6.4.5 Krosyl Pharma Recent Developments
6.5 Iskon Remedies
6.5.1 Iskon Remedies Comapny Information
6.5.2 Iskon Remedies Business Overview
6.5.3 Iskon Remedies Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Iskon Remedies Dry Powder Injectables Product Portfolio
6.5.5 Iskon Remedies Recent Developments
6.6 Flagship Biotech International Pvt Ltd
6.6.1 Flagship Biotech International Pvt Ltd Comapny Information
6.6.2 Flagship Biotech International Pvt Ltd Business Overview
6.6.3 Flagship Biotech International Pvt Ltd Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Flagship Biotech International Pvt Ltd Dry Powder Injectables Product Portfolio
6.6.5 Flagship Biotech International Pvt Ltd Recent Developments
6.7 Cosmas Pharmacls
6.7.1 Cosmas Pharmacls Comapny Information
6.7.2 Cosmas Pharmacls Business Overview
6.7.3 Cosmas Pharmacls Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cosmas Pharmacls Dry Powder Injectables Product Portfolio
6.7.5 Cosmas Pharmacls Recent Developments
6.8 Captab Biotec
6.8.1 Captab Biotec Comapny Information
6.8.2 Captab Biotec Business Overview
6.8.3 Captab Biotec Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Captab Biotec Dry Powder Injectables Product Portfolio
6.8.5 Captab Biotec Recent Developments
6.9 Bliss GVS
6.9.1 Bliss GVS Comapny Information
6.9.2 Bliss GVS Business Overview
6.9.3 Bliss GVS Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bliss GVS Dry Powder Injectables Product Portfolio
6.9.5 Bliss GVS Recent Developments
6.10 Aqua Vitoe Lab
6.10.1 Aqua Vitoe Lab Comapny Information
6.10.2 Aqua Vitoe Lab Business Overview
6.10.3 Aqua Vitoe Lab Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Aqua Vitoe Lab Dry Powder Injectables Product Portfolio
6.10.5 Aqua Vitoe Lab Recent Developments
6.11 ANG Lifesciences
6.11.1 ANG Lifesciences Comapny Information
6.11.2 ANG Lifesciences Business Overview
6.11.3 ANG Lifesciences Dry Powder Injectables Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ANG Lifesciences Dry Powder Injectables Product Portfolio
6.11.5 ANG Lifesciences Recent Developments
7 North America by Country
7.1 North America Dry Powder Injectables Sales by Country
7.1.1 North America Dry Powder Injectables Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Dry Powder Injectables Sales by Country (2020-2025)
7.1.3 North America Dry Powder Injectables Sales Forecast by Country (2026-2031)
7.2 North America Dry Powder Injectables Market Size by Country
7.2.1 North America Dry Powder Injectables Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Dry Powder Injectables Market Size by Country (2020-2025)
7.2.3 North America Dry Powder Injectables Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Dry Powder Injectables Sales by Country
8.1.1 Europe Dry Powder Injectables Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Dry Powder Injectables Sales by Country (2020-2025)
8.1.3 Europe Dry Powder Injectables Sales Forecast by Country (2026-2031)
8.2 Europe Dry Powder Injectables Market Size by Country
8.2.1 Europe Dry Powder Injectables Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Dry Powder Injectables Market Size by Country (2020-2025)
8.2.3 Europe Dry Powder Injectables Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Dry Powder Injectables Sales by Country
9.1.1 Asia-Pacific Dry Powder Injectables Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Dry Powder Injectables Sales by Country (2020-2025)
9.1.3 Asia-Pacific Dry Powder Injectables Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Dry Powder Injectables Market Size by Country
9.2.1 Asia-Pacific Dry Powder Injectables Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Dry Powder Injectables Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Dry Powder Injectables Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Dry Powder Injectables Sales by Country
10.1.1 South America Dry Powder Injectables Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Dry Powder Injectables Sales by Country (2020-2025)
10.1.3 South America Dry Powder Injectables Sales Forecast by Country (2026-2031)
10.2 South America Dry Powder Injectables Market Size by Country
10.2.1 South America Dry Powder Injectables Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Dry Powder Injectables Market Size by Country (2020-2025)
10.2.3 South America Dry Powder Injectables Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Dry Powder Injectables Sales by Country
11.1.1 Middle East and Africa Dry Powder Injectables Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Dry Powder Injectables Sales by Country (2020-2025)
11.1.3 Middle East and Africa Dry Powder Injectables Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Dry Powder Injectables Market Size by Country
11.2.1 Middle East and Africa Dry Powder Injectables Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Dry Powder Injectables Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Dry Powder Injectables Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Dry Powder Injectables Value Chain Analysis
12.1.1 Dry Powder Injectables Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Dry Powder Injectables Production Mode & Process
12.2 Dry Powder Injectables Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Dry Powder Injectables Distributors
12.2.3 Dry Powder Injectables Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.